Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002182042 | SCV002338838 | likely benign | Primary dilated cardiomyopathy | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002398151 | SCV002709995 | uncertain significance | Cardiovascular phenotype | 2021-05-17 | criteria provided, single submitter | clinical testing | The c.156G>A variant (also known as p.L52L), located in coding exon 2 of the TXNRD2 gene, results from a G to A substitution at nucleotide position 156. This nucleotide substitution does not change the at codon 52. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |